Loading
Thoracic oncologist and tumour immunologist who chairs the Cancer Research Institute Ghent at Ghent University / UZ Gent.
Karim Vermaelen is Chairperson of the Steering Committee of the Cancer Research Institute Ghent (CRIG) for 2026-2028, the interfaculty cancer research institute linking Ghent University, Ghent University Hospital and VIB. A thoracic oncologist at UZ Gent, his research focuses on tumour immunology and immunotherapy of lung cancer, including dendritic-cell and vaccine approaches.
| Title | Journal | Year |
|---|---|---|
| Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses | Frontiers in Immunology | 2019 |
| Dendritic Cell-Based Immunotherapy in Lung Cancer | Frontiers in Immunology | 2020 |
| The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome | OncoImmunology | 2016 |
Shares Mesothelioma, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer, immunotherapy.
Shares Mesothelioma, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags clinician-scientist, lung cancer, immunotherapy.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.